PepGen (PEPG) Return on Equity [ROE] (2022 - 2026)
PepGen's Return on Equity [ROE] was -56.72% in Q2 2026, up 62.98 percentage points from -119.70% a year earlier but down 1.88 percentage points from the prior quarter.
Powered by 
Analysis
PepGen (PEPG) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at PepGen came in at -67.39%, up 11.87 percentage points from FY2024.
- Return on Equity [ROE] shows a three-year change of +26.27 percentage points (FY2022 to FY2025).
- In earlier years, Return on Equity [ROE] was -79.26% in FY2024 (-24.65 pp), -54.61% in FY2023 (+39.05 pp) and -93.66% in FY2022.
- Quarterly Return on Equity [ROE] has moved between -119.70% (Q2 2025) and -30.42% (Q3 2022) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of -2.40 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2026 (a gain of 62.98 percentage points); the worst was Q2 2025 (a drop of 66.37 percentage points).
- Per Business Quant data, PEPG's Return on Equity [ROE] in the three quarters before Q2 2026 was -54.84% (Q1 2026), -57.70% (Q4 2025) and -80.39% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | PepGen | 319.29 Mn | -183.51 Mn | - | -65.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -65.99% |
| Jun 30, 2026 | -56.81% |
| Mar 31, 2026 | -54.90% |
| Dec 31, 2025 | -57.74% |
| Sep 30, 2025 | -79.96% |
| Jun 30, 2025 | -118.90% |
| Mar 31, 2025 | -97.09% |
| Dec 31, 2024 | -70.29% |
| Sep 30, 2024 | -59.55% |
| Jun 30, 2024 | -53.42% |
| Mar 31, 2024 | -55.90% |
| Dec 31, 2023 | -67.07% |
| Sep 30, 2023 | -54.25% |
| Jun 30, 2023 | -44.43% |
| Mar 31, 2023 | -39.00% |
| Dec 31, 2022 | -37.09% |
| Sep 30, 2022 | -30.42% |
| Jun 30, 2022 | -63.27% |
API Access
PepGen Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PEPG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PEPG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PEPG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();